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Abstract Casein kinase IO (CKIO), a central component of the
circadian clock, interacts with and phosphorylates human period
protein 1 (hPER1) [Keesler, G.A. et al. (2000) NeuroReport 5,
951^955]. A mutation in CKIO causes a shortened circadian
period in Syrian Golden hamster. We have now extended our
previous studies to show that human casein kinase IN (hCKIN),
the closest homologue to hCKIO, associates with and phosphor-
ylates hPER1 and causes protein instability. Furthermore, we
observed that both hCKIN and hCKIO phosphorylated and caused
protein instability of human period 2 protein (hPER2).
Immunohistochemical staining of rat brains demonstrates that
CKIN protein is localized in the suprachiasmatic nuclei, the
central location of the master clock. These results indicate that
CKIN may play a role similar to CKIO, suggesting that it may
also be involved in regulating circadian rhythmicity by post-
translation modification of mammalian clock proteins hPER1
and 2. ß 2001 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Circadian rhythms are present in a diverse number of or-
ganisms including mammals, fungi, plants, insects, and cya-
nobacterium [2^4]. The control of biochemical, physiological,
and behavioral processes is regulated by endogenous biologi-
cal clocks whose components are relatively conserved among
these organisms [5,6]. In mammals, the suprachiasmatic nu-
cleus (SCN) is the site of the central pacemaker or ‘gears’ of
the clock, and is responsible for resetting and controlling the
clocks within the peripheral tissues [7^9]. One important com-
ponent within the central clock is the period (PER) proteins
whose function is critical in maintaining constant daily
rhythms.
In mammals, three PER proteins have been identi¢ed:
PER1, 2 and 3. All PER mRNAs and protein levels oscillate
during the circadian day and are intimately involved in both
the positive and negative regulation of the biological clock
[10^12]. The function of PER3 is poorly understood; how-
ever, mPer3 knockout mice have a subtle e¡ect on circadian
activity, and therefore have been suggested to be involved in
the circadian controlled output pathways [13]. PER2 is the
most well-characterized protein, and mPER2 mutant mice
(mPer2brdm1), lacking 87 residues at the carboxyl portion of
the PAS dimerization domain, have a shortened circadian
cycle in normal light^dark settings, but show arrhythmicity
in complete darkness [14]. Shearman et al. [15] have shown
that PER2 has a dual function in the regulation of the ‘gears’
of the central clock. In their study, PER2 binds to crypto-
chrome (CRY) proteins and translocates to the nucleus where
CRY negatively regulates transcription driven by CLOCK
and BMAL1 positive transcriptional complexes. Upon nuclear
entry, PER2 initiates the positive arm of the clock by posi-
tively regulating BMAL1 transcription by a yet unidenti¢ed
mechanism. PER1 is believed to be involved in the negative
regulation of its own transcription in the feedback loop, but
recent evidence points to it being involved in the input path-
way [16]. In cell culture models, PER1 protein levels are also
regulated post-translationally. PER1 protein phosphorylation
leads to a decrease in cellular PER1 protein levels presumably
through enhanced protein degradation rates [1,17].
To date, only one kinase has been discovered as a central
clock component [18]. Young and colleagues ¢rst identi¢ed a
kinase-like Drosophila protein, doubletime (DBT) that is
thought to phosphorylate Drosophila PER [19,20]. Missense
mutations in dbt result in an altered circadian rhythm. Null
alleles of dbt result in hypophosphorylation of dPER and
arrhythmia. The mammalian kinases most closely related to
DBT are casein kinase I (CKI)O and CKIN. Both kinases have
been shown to bind to mPER1, and several studies have
shown that CKIO phosphorylates both mouse and human
PER1 [19,20]. The consequence of PER1 phosphorylation
by hCKIO includes both cytoplasmic retention and protein
instability [17,21]. There has been no biochemical reason to
choose between CKIO or CKIN as a potential regulator in
mammals until Lowery et al. [18] found that in the Syrian
Golden hamster, semidominant mutations in CKIO (tau)
caused a shortened circadian day in both heterozygous (22
h) and homozygous animals (20 h) [22]. In this instance, re-
duced levels of CKIO activity resulted in less PER phosphor-
ylation with presumably higher levels of cytoplasmic PER
protein leading to enhanced nuclear entry and altered circa-
dian cycles.
Of the seven identi¢ed CKI isoforms, CKIN is the closest
homologue of CKIO. The kinase domains of both of these
0014-5793 / 01 / $20.00 ß 2001 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 0 ) 0 2 4 3 4 - 0
*Corresponding author. Fax: (1)-908-231 4335.
E-mail: george.keesler@aventis.com
FEBS 24521 25-1-01 Cyaan Magenta Geel Zwart
FEBS 24521 FEBS Letters 489 (2001) 159^165
proteins are 97% identical with only eight amino acid changes
[23,24]. While the identi¢cation of mutant CKIO in the tau
mutant hamster suggests CKIO is the important circadian reg-
ulator, an alternative hypothesis is that the tau mutation ren-
ders CKIO a dominant interfering kinase that may block the
function of CKIO and CKIN in the SCN. In this study, we set
out to determine if hCKIN was capable of playing a similar
role as hCKIO in the phosphorylation of human clock proteins
PER1 and 2.
2. Materials and methods
2.1. Plasmids
Mammalian expression vectors pCEP4-CKIO and pCEP4-CKIN
were constructed as described [24]. Full-length hPER1 kindly pro-
vided by Dr. Y. Sakaki [25] was ligated into plasmid vector pEYFP
(Clonetech, Palo Alto, CA, USA) to create an in-frame fusion with
the YFP-tag. Full-length open reading frame (ORF) hPER2 was
cloned by PCR from a human brain cDNA library from Clonetech
using the forward primer ATCTAGATCTAGAATGAATGGA-
TACGCGGAATTTCCG and the reverse primer TCTGCTCGAGT-
CAAGGGGGATCCATTTTCGTCTT. The ORF encodes a 1246
amino acid protein. The DNA was subcloned into the pEYFP living
color vector (Clonetech) creating a hPER2^N-terminal YFP fusion
protein. All constructs were con¢rmed by DNA sequence analysis.
2.2. Transfection and radiolabeling of HEK 293T cells
Human embryonic kidney cells HEK 293T were cultured and trans-
fected via lipofectamine plus (Gibco BRL Life Technologies, Rock-
ville, MD, USA) according to the manufacturer’s protocols. HEK
293T cells were radiolabeled 16 h post-transfection with 0.5 mCi/ml
[35S]methionine/cysteine (NEN, Boston, MA, USA) for 30 min in
methionine and cysteine de¢cient media. Thereafter, cells were washed
and lysates were prepared as described [1].
2.3. Immunoprecipitations and Western blot analysis
Lysates containing equal amounts of protein (100 mg total) were
mixed with 5 Wl of anti-YFP, anti-hematoxylin (HA), or anti-c-myc
monoclonal antibody (mAb) and immunoprecipitated. Western blot-
ting of proteins was performed using either anti-YFP at a 1:1000
dilution, anti-HA at 1:1000 dilution, or anti-c-myc at a 1:1000 dilu-
tion (Santa Cruz Biotech, Santa Cruz, CA, USA). Secondary anti-
bodies (Gibco BRL Life Technologies) anti-rabbit horseradish peroxi-
dase (HRP) were used at a 1:5000 dilution.
2.4. Immunohistochemistry
Male Sprague Dawley rats weighing 250^350 g were housed in
plastic cages with free access to food and water, and a 12 h light^
12 h dark cycle. Rats were anesthetized with chloral hydrate and were
perfused through the heart with 200 ml saline, followed by 500 ml of
4% formaldehyde (phosphate-bu¡ered saline (PBS) 0.01 M, pH 7.4).
The brains were post-¢xed overnight and cryoprotected in 30% su-
crose in phosphate bu¡er prior to being frozen and sectioned to 30 Wm
in the coronal plane. Free-£oating sections were incubated in 0.5%
H2O2 for 30 min then washed in PBS (3U5 min) and blocked for 1 h
in 10% mouse serum. The tissue was then incubated in anti-rat CKIN
antibody 1:500 dilution (R19 Santa Cruz Biotech) for 48 h at 4‡C in
bu¡er containing the primary antibody plus 2% mouse serum. Sec-
tions were rinsed in PBS, then incubated in biotin-labeled mouse anti-
goat (1:1000 dilution) (Jackson Labs, Bar Harbor, ME, USA) for 1 h.
The tissue was then incubated in avidin^HRP conjugate from the
Vectastain Elite ABC kit (Vector Laboratories, Burlingame, CA,
USA) according to the manufacturer’s instructions. CKIN immunore-
activity was visualized by incubating the avidin^HRP with H2O2 cat-
alyzed 3,3P-diaminobenzidine-4HCL localization. Sections were
mounted on gel-subbed slides and allowed to air dry prior to being
dehydrated in a graded series of alcohols to xylene and then cover-
slipped. Selected sections were counter-stained with HA prior to being
coverslipped. The tissue was evaluated on an Olympus AX-70 micro-
scope and captured with a Sony STU-5 digital camera employing a
Media Cybernetics Pro-Series 128 bit frame grabber board. Images
were then transferred to a Dell Optiplex GX300 workstation utilizing
Image ProPlus 4.0 image software.
3. Results
3.1. hCKIN phosphorylates hPER1 and hPER2
To determine whether hCKIN could phosphorylate hPER1,
YFP-tagged hPER1 expression plasmid was co-transfected
into HEK 293T cells with either hCKIN or vector control.
Co-transfection of hCKIN with hPER1 resulted in a signi¢-
cant shift in molecular mass of hPER1 proteins as compared
to hPER1 co-transfected with vector alone as demonstrated
by Western analysis (Fig. 1, lanes 2 and 4). The change in
molecular mass of hPER1 after co-transfection with hCKIN is
most likely due to a post-translation modi¢cation by phos-
phorylation for two reasons. The ¢rst is that co-transfected
cells incubated with [32P]ATP showed signi¢cant incorpora-
tion of radioactive label in the hPER proteins, and second
samples treated with lambda phosphatase reduced the gel shift
to control levels (data not shown).
We have previously found that hCKIO phosphorylates
hPER1 in co-transfected HEK 293T cells (see Fig. 1, lane
3). We therefore sought to determine if both hCKIN or hCKIO
could phosphorylate another clock protein, hPER2. YFP-
tagged hPER2 expression plasmid was co-transfected into
HEK 293T cells with either vector control, hCKIN or hCKIO.
As shown in Fig. 1, cells co-transfected with hPER2 and
hCKIN or hCKIO show a shift molecular mass of hPER2
protein that is not apparent in the hPER2 singly transfected
cells (Fig. 1, lanes 5^7), indicating that both kinases could
phosphorylate hPER2.
Fig. 1. Phosphorylation of hPER1 and hPER2 by recombinant
hCKIN or hCKIO in transfected cells, and Western blot analysis of
hPER1, hPER2, hCKIN, and hCKIO. HEK 293T cells were trans-
fected with vector alone or with hPER1 or hPER2 (lanes 1, 2, and
5), hPER1 and hCKIN (lane 4), hPER2 and hCKIN (lane 7), or
hPER1 and hCKIO (lane 3), or hPER2 and hCKIO (lane 6). At 16 h
post-transfection, cells were harvested and lysates were prepared as
described in Section 2. 20 mg of total protein from HEK 293T ly-
sates was loaded onto a 3^8% gradient SDS^PAGE. Proteins were
transferred to PVDF membranes and Western-blotted using the
anti-YFP mAb (1:1000), or anti-c-myc (hCKIN) mAb (1:1000), or
anti-HA (hCKIO) mAb (1:1000).
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3.2. hCKIN physically associates with hPER1 and hPER2 in
HEK 293T cells
Because hCKIN can phosphorylate hPER1 and hPER2 pro-
teins, we next asked if hCKIN associated or interacted with
hPER1 and hPER2 in co-transfected cells. To determine this,
we expressed c-myc-tagged hCKIN, YFP-hPER1, YFP-
hPER2, or vector control in HEK 293T cells. HA-tagged
hCKIO expression plasmid was used as a positive control.
Cells were lysed and either immunoprecipitated with anti-c-
myc mAb (hCKIN) or anti-HA mAb (hCKIO) and Western-
blotted with either anti-YFP mAb, and in the reciprocal ex-
periment immunoprecipitated with anti-YFP mAb (hPER)
and Western-blotted with anti-c-myc or anti-HA mAb. As
shown in Fig. 2, immunoprecipitating with anti-c-myc mAb
and Western blotting with anti-YFP mAb revealed the ap-
pearance of hPER1 and 2 proteins (lanes 3 and 4; upper
panels). Identical results were found for hCKIO by immuno-
precipitating with anti-HA mAb (lanes 7 and 8; upper pan-
els). Furthermore, the reciprocal experiment of immunopre-
cipitating with anti-YFP mAb followed by Western blotting
with anti-c-myc mAb or anti-HA mAb shows hCKIN and
hCKIO protein (lanes 3, 4, 7, and 8; lower panels). These
data indicate that hCKIN interacts with both hPER1 and 2
in co-transfected cells.
3.3. Phosphorylation of hPERs by hCKIN leads to hPER
protein destabilization
It has been postulated that accumulation of PER protein
could result in both a negative and positive e¡ect on the
central clock and that phosphorylation of PER might be a
key post-translational event in regulating the PER protein
levels. We therefore determined whether hCKIN phosphoryla-
tion of hPER1 and hPER2 a¡ected their protein stability.
HEK 293T cells were co-transfected with expression plasmids
encoding either hPER1 or hPER2 alone or hPER1 and
hPER2 together and with or without hCKIN, or vector con-
trol. HA-tagged hCKIO expression plasmid was used as a
positive control. 16 h post-transfection, cells were pulse-la-
beled with [35S]methionine and chased for the times indicated.
As expected, cells co-transfected with hPER1 or hPER2 and
vector showed a gradual minimal shift in electrophoretic mo-
bility and the protein levels remained relatively constant
throughout the time course (Fig. 3A,D, lanes 1^7). At later
time points (16 and 24 h) both hPER1 and hPER2 showed a
minimal shift in their molecular masses with the shift in
hPER1 being more apparent. This is most likely due to phos-
phorylation by either endogenous CKI and/or as of yet un-
identi¢ed additional kinase(s). However, in cells co-trans-
fected with hCKIN, hPER1 or hPER2 showed a rapid
mobility shift as early as 4 h post-pulse, and reached a max-
imum between 8 and 16 h (Fig. 3B,E). Half-life estimates of
hPER1 protein showed that in the vector control approxi-
mately 50% of the protein remained in the cells at the 24 h
time point (Fig. 3A). Conversely, hPER1 protein levels after
phosphorylation with hCKIN revealed that only 50% of the
protein remained after 8 h and less than 20% remained after
24 h and similar to our previously reported results with
hCKIO (Fig. 3B,C) [1]. It is interesting to note that the
hPER1 mobility shift was more pronounced than that of
hPER2 suggesting that hPER1 is phosphorylated to a greater
extent than hPER2 (Fig. 3B,E). It also appears that hPER2 is
slightly more stable than hPER1 after phosphorylation by
hCKIN (Fig. 3B,E). The estimated half-life of hPER2 protein
after phosphorylation with hCKIN was similar to the vector
control after 16 h in which approximately 50% of the total
protein is present. The signi¢cant di¡erences in hPER2 pro-
tein levels were only apparent at the 24 h time point in which
50% of the protein remains in the vector control and less than
25% of the protein remains after phosphorylation with hCKIN
(Fig. 3D,E). Similar results were found when hCKIO was co-
transfected in replace of hCKIN with either hPER1 or hPER2
(Fig. 3C,F).
PER1 and PER2 have been shown to form heterodimers
when co-expressed. However, there appears to be no advan-
tage with regard to hPER protein stability after phosphoryla-
tion by hCKIN when both hPER1 and 2 are co-expressed. As
shown in Fig. 3G,H, co-transfection of hPER1 and hPER2 in
the presence of hCKIN also led to degradation of the hPER
proteins, and in particular hPER1, with an estimated half-life
Fig. 2. Protein^protein interaction between hPER1, hPER2, and
hCKIN, or hCKIO. HEK 293T cells were transfected with vector
and hCKIN (lane 1), vector and hCKIO (lane 5), vector and hPER1
(lane 2), vector and hPER2 (lane 6) or hCKIN and hPER1 (lane 3),
hCKIN and hPER2 (lane 4), hCKIO and hPER1 (lane 7), or hCKIO
and hPER2 (lane 8). 16 h post-transfection, cells were harvested
and lysates were prepared. Lysates were immunoprecipitated with ei-
ther anti-c-myc mAb (upper panel, lanes 1^4), anti-HA mAb (upper
panel, lanes 5^8), or with anti-YFP mAb (lower panels, lanes 1^8)
and Western-blotted with anti-YFP mAb (upper panels, lanes 1^8),
anti-c-myc mAb (lower panel, lanes 1^4), or anti-HA mAb (lower
panel, lanes 5^8). All proteins were resolved on a 12% SDS^PAGE.
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similar to either hPER expressed singly in the presence of
kinase (Fig. 3B,E,H).
3.4. CKIN protein is expressed in the SCN
Given that the central clock is localized in the SCN, and
CKIN can phosphorylate and associate with the clock compo-
nents hPER1 and 2, we determined whether CKIN is expressed
in SCN. To this end, we performed immunohistochemical
studies on coronal sections of rat brain using a CKIN speci¢c
polyclonal antibody. As shown in Fig. 4, examination of co-
ronal sections containing the SCN demonstrated intense, lo-
calized immunoreactivity of CKIN protein within this well-
de¢ned region as well as in both cortical and subcortical neu-
rons (Fig. 4A). Higher magni¢cation (Fig. 4A, inset) of this
region showed that virtually all cells within the SCN stained
positive for CKIN protein. Examination of SCN at higher
magni¢cation (Fig. 4B) demonstrated that immunoreactivity
was predominantly localized to nuclear pro¢les; although
weak immunoreactivity could be observed in cytoplasm and
to a lesser extent in neuronal processes. Based on the broad
expression of CKIN immunoreactivity observed in rat brain,
we examined the localization of this protein in hippocampus
(Fig. 4C). As in the SCN, CKIN protein was localized pre-
dominantly to neuronal populations and was essentially ab-
sent in neuron free regions such as dentate gyrus molecular
layer and corpus callosum. Immunoreactivity was most appar-
ent in the ventral leaf of the dentate gyrus (VLDG) granule
cell layer, although weak expression of CKIN protein was also
observed in the dorsal leaf of the dentate gyrus (DLDG)
granule cell layer, subiculum and hippocampal pyramidal
cell layer. Examination of neurons of the VLDG granule
cell layer revealed that CKIN protein was not present in nu-
clear pro¢les, but was instead localized to peri-nuclear cyto-
plasm (Fig. 4C, inset). This di¡erential subcellular localization
within neurons of the dentate gyrus and the SCN was con-
sistently observed in all animals examined.
4. Discussion
4.1. Human PER1 and PER2 are substrates for hCKIN
The role of CKI in the regulation of circadian rhythms is
becoming increasingly apparent. Phosphorylation of PER
Fig. 3. Pulse-chase labeling of hPER1 and hPER2 co-transfected with hCKIN, hCKIO, or vector. HEK 293T cells were co-transfected with ei-
ther hPER1 and vector (A), hPER1 and hCKIN (B), hPER1 and hCKIO (C), hPER2 and vector (D), hPER2 and hCKIN (E), hPER2 and
hCKIO (F), hPER1, hPER2 and vector (G), or hPER1, hPER2, and hCKIN (H). 16 h post-transfection, HEK 293T cells were pulse-labeled
with [35S]methionine and cysteine (500 mCi/ml) for 30 min and then chased for the times (h) indicated at the top of each gel. Cells were lysed
and immunoprecipitated with anti-YFP mAb and the hPER proteins were resolved on 8% SDS^PAGE.
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proteins by CKI(s) in the cell appears to be a key event in
both the positive and negative regulation of the cycle
[1,17,18,21]. As the circadian day progresses, PER protein
accumulates and becomes phosphorylated and degraded;
therefore, any perturbation of the phosphorylation event
may alter the cellular levels of PER and change the homeo-
stasis of the circadian cycle. A recent report by Lowery et al.
[18] demonstrates this elegantly in the identi¢cation of the tau
Fig. 4. Immunohistochemical staining for CKIN in rat brain cross sectional samples. A: Rat brain coronal sections (15U magni¢cation) con-
taining the SCN showing positive staining CKIN in the SCN and optic chiasm (OC), insert is 100U higher magni¢cation of SCN cells.
B: 100U magni¢cation of rat brain coronal sections showing SCN neurons staining for CKIN. Note the appearance of CKIN nuclear localiza-
tion within the SCN neurons. C: Rat brain cross sectional staining showing CKIN immunoreactivity in dentate gyrus (VLDG, DLDG), and
hippocampal pyramidal layers (PCL). Insert is 100U magni¢cation showing staining in the peri-nuclear space of the neurons.
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mutant as a CKIO defect. Although CKIO is active in the tau
mutant, it has less than 10% of wild-type activity suggesting
that phosphorylation of PER proteins is perturbed leading to
altered cellular PER protein levels and localization. In our
own circadian mathematical modeling studies, it was deter-
mined that slight alterations of kinase activity resulting in
decreased PER phosphorylation resulted in extreme changes
(a shortening) in the circadian daily cycle [26].
Our previous ¢ndings demonstrated that hCKIO and
hPER1 interact, hCKIO could phosphorylate hPER1, and
that the consequence of hPER1 phosphorylation is destabili-
zation of hPER1 protein [1]. This study furthers these obser-
vations, demonstrating that hCKIN can interact with and
phosphorylate hPER1 and hPER2. This is not unexpected
due to the close homology between hCKIO and hCKIN in
the kinase domain. Perhaps the phosphorylation of PERs is
a general signaling mechanism to target the proteins for deg-
radation. Although Vielhaber et al. found that phosphoryla-
tion of mPER1 by hCKIO causes cytoplasmic retention in
HEK 293T cells, we have found no evidence for that to be
the case with hPER2 (unpublished observation), nor have we
found that hPER phosphorylation alters hetero- or homo-
dimer formation between the PERs.
4.2. hCKIN and hCKIO may have redundant roles in PER
post-translational regulation
If PER phosphorylation is a mechanism of regulation, and
since PER protein levels oscillate during the day, then how
does CKI become active at the appropriate time during the
day and phosphorylate PER? hCKIO and hCKIN are consti-
tutively active kinases; therefore, a simple explanation is that
PER phosphorylation occurs when intracellular protein levels
reach a critical mass for enzyme substrate interaction. Anoth-
er explanation is that hCKIO or hCKIN mRNA levels may
oscillate during the day similar to hPER1, 2 and 3 but are
delayed by several hours. As PER protein levels begin to
accumulate, CKI protein levels increase which results in the
phosphorylation of PER. Although, Lowery et al. [18] found
no evidence for CKIO oscillation and dbt mRNA levels do not
£uctuate [19]. However, we are currently exploring this hy-
pothesis.
Another question that remains is the possible redundant
roles of CKIO and CKIN in the phosphorylation of PERs.
The data by Takahashi and colleagues [18] demonstrate that
a hypomorphic allele of CKIO can alter circadian rhythm and
those results may render CKIN as having a minor role in
circadian biology. An alternative hypothesis is that the tau
mutant CKIO acts as a dominant negative kinase that binds
to the PER proteins, fails to phosphorylate them, but also
prevents other kinases, in particular CKIN, from e⁄ciently
phosphorylating the bound PERs. In fact, experiments by
our laboratory and Veilhaber et al. [17] have shown that
hCKIO kinase negative mutants interact and associate with
PER in co-transfected cells. Another possibility is that CKIO
is the primary kinase in the SCN while CKIN acts on PER in
the periphery. However this may not be the case because of
the intense CKIN staining we observed in the rat SCN. Fur-
thermore, CKIN phosphorylation of PER might be just a con-
sequence of the close homology in the kinase domain between
the two proteins; however, we have not found evidence to
suggest that other CKI isoforms e⁄ciently phosphorylate
PERs. In fact, in CKIK and CKIQ co-transfection experiments
with the hPERs, we have found limited mobility shifts and
32PO4 incorporation into PER1 and 2 (unpublished observa-
tion). Furthermore, we have not been able to demonstrate any
interaction between CKIK and hPER1 or 2 in either a yeast
two hybrid or co-immunoprecipitation assay [17].
4.3. CKIN as a component of the mammalian clock
Our studies have shown that both hPER1 and hPER2 are
substrates for the closely related CKI isoforms N and O. Not
only do both kinases interact with hPER1 and 2, but they also
both e⁄ciently phosphorylate the proteins and cause a shift in
the molecular mass of the protein. More importantly, phos-
phorylation of the PERs causes the proteins, in particular
hPER1, to become unstable or degraded suggesting that phos-
phorylation is a key step in the regulation of cellular PER
levels and in the regulation of the circadian cycle in mammals.
Our data suggest that both hCKIN and hCKIO are positioned
to contribute to phosphorylation and destabilization of PER
in the SCN. If in fact CKIN is also a regulator of the central
clock, then we would predict that expression of hypomorphic
alleles of CKIN in the SCN will also act as dominant negatives
and result in the tau phenotype of period shortening.
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